Skip to main content
Erschienen in: Advances in Therapy 5/2016

02.03.2016 | Review

Current Perspectives of Prophylaxis and Management of Acute Infective Endophthalmitis

verfasst von: Paris Tranos, Nikolaos Dervenis, Athanasios N. Vakalis, Solon Asteriadis, Panagiotis Stavrakas, Anastasios G. P. Konstas

Erschienen in: Advances in Therapy | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

Endophthalmitis is an intraocular inflammatory condition which may or may not be caused by infective agents. Noninfectious (sterile) endophthalmitis may be attributable to various causes including postoperative retained soft lens matter or toxicity following introduction of other agents into the eye. Infectious endophthalmitis is further subdivided into endogenous and exogenous. In endogenous endophthalmitis there is hematogenous spread of organisms from a distant source of infection whereas in exogenous endophthalmitis direct microbial inoculation may occur usually following ocular surgery or penetrating eye injury with or without intraocular foreign bodies. Acute infective endophthalmitis is usually exogenous induced by inoculation of pathogens following ocular surgery, open-globe injury and intravitreal injections. More infrequently the infective source is internal and septicemia spreads to the eye resulting in endogenous endophthalmitis. Several risk factors have been implicated including immunosuppression, ocular surface abnormalities, poor surgical wound construction, complicated cataract surgery with vitreous loss and certain types of intraocular lens. Comprehensive guidelines and recommendations on prophylaxis and monitoring of surgical cases have been proposed to minimize the risk of acute endophthalmitis. Early diagnosis and prompt management of infective endophthalmitis employing appropriately selected intravitreal antibiotics are essential to optimize visual outcome.
Literatur
1.
Zurück zum Zitat Barry P, Cordovés L, Gardner S. ESCRS guidelines for prevention and treatment of endophthalmitis following cataract surgery: data, dilemmas and conclusions. Dublin: European Society of Cataract and Refractive Surgeons; 2013. Barry P, Cordovés L, Gardner S. ESCRS guidelines for prevention and treatment of endophthalmitis following cataract surgery: data, dilemmas and conclusions. Dublin: European Society of Cataract and Refractive Surgeons; 2013.
2.
Zurück zum Zitat Pathengay A, Flynn HW Jr, Isom RF, Miller D. Endophthalmitis outbeaks following cataract surgery: causative organisms, etiologies and visual acuity outcomes. J Cataract Refract Surg. 2012;38(7):1278–82.PubMedCrossRef Pathengay A, Flynn HW Jr, Isom RF, Miller D. Endophthalmitis outbeaks following cataract surgery: causative organisms, etiologies and visual acuity outcomes. J Cataract Refract Surg. 2012;38(7):1278–82.PubMedCrossRef
3.
Zurück zum Zitat Simunovic MP, Rush RB, Hunyor AP, Chang AA. Endophthalmitis following intravitreal injection versus endophthalmitis following cataract surgery: clinical features, causative organisms and post-treatment outcomes. Br J Ophthalmol. 2012;96(6):862–6.PubMedCrossRef Simunovic MP, Rush RB, Hunyor AP, Chang AA. Endophthalmitis following intravitreal injection versus endophthalmitis following cataract surgery: clinical features, causative organisms and post-treatment outcomes. Br J Ophthalmol. 2012;96(6):862–6.PubMedCrossRef
4.
Zurück zum Zitat Sadaka A, Durand ML, Gilmore MS. Bacterial endophthalmitis in the age of outpatient intravitreal therapies and cataract surgeries: host–microbe interactions in intraocular infection. Prog Retin Eye Res. 2012;31(4):316–31.PubMedPubMedCentralCrossRef Sadaka A, Durand ML, Gilmore MS. Bacterial endophthalmitis in the age of outpatient intravitreal therapies and cataract surgeries: host–microbe interactions in intraocular infection. Prog Retin Eye Res. 2012;31(4):316–31.PubMedPubMedCentralCrossRef
5.
Zurück zum Zitat Keay L, Gower EW, Cassard SD, Tielsch JM, Schein OD. Postcataract surgery endophthalmitis in the United States: analysis of the complete 2003 to 2004 Medicare database of cataract surgeries. Ophthalmology. 2012;119(5):914–22.PubMedPubMedCentralCrossRef Keay L, Gower EW, Cassard SD, Tielsch JM, Schein OD. Postcataract surgery endophthalmitis in the United States: analysis of the complete 2003 to 2004 Medicare database of cataract surgeries. Ophthalmology. 2012;119(5):914–22.PubMedPubMedCentralCrossRef
6.
Zurück zum Zitat Freeman EE, Roy-Gagnon M-H, Fortin E, Gauthier D, Popescu M, Boisjoly H. Rate of endophthalmitis after cataract surgery in Quebec, Canada, 1996–2005. Arch Ophthalmol. 2010;128(2):230–4.PubMedCrossRef Freeman EE, Roy-Gagnon M-H, Fortin E, Gauthier D, Popescu M, Boisjoly H. Rate of endophthalmitis after cataract surgery in Quebec, Canada, 1996–2005. Arch Ophthalmol. 2010;128(2):230–4.PubMedCrossRef
7.
Zurück zum Zitat Kodjikian L, Salvanet-Bouccara A, Grillon S, Forestier F, Seegmuller J-L, Berdeaux G, et al. Postcataract acute endophthalmitis in France: national prospective survey. J Cataract Refract Surg. 2009;35(1):89–97.PubMedCrossRef Kodjikian L, Salvanet-Bouccara A, Grillon S, Forestier F, Seegmuller J-L, Berdeaux G, et al. Postcataract acute endophthalmitis in France: national prospective survey. J Cataract Refract Surg. 2009;35(1):89–97.PubMedCrossRef
8.
Zurück zum Zitat Taban M, Behrens A, Newcomb RL, Nobe MY, Saedi G, Sweet PM, et al. Acute endophthalmitis following cataract surgery: a systematic review of the literature. Arch Ophthalmol. 2005;123(5):613–20.PubMedCrossRef Taban M, Behrens A, Newcomb RL, Nobe MY, Saedi G, Sweet PM, et al. Acute endophthalmitis following cataract surgery: a systematic review of the literature. Arch Ophthalmol. 2005;123(5):613–20.PubMedCrossRef
9.
Zurück zum Zitat Leopold I. Incidence of endophthalmitis after cataract surgery. Trans Ophthalmol Soc UK. 1971;191:575–609. Leopold I. Incidence of endophthalmitis after cataract surgery. Trans Ophthalmol Soc UK. 1971;191:575–609.
10.
Zurück zum Zitat Aaberg TM, Flynn HW, Schiffman J, Newton J. Nosocomial acute-onset postoperative endophthalmitis survey: a 10-year review of incidence and outcomes. Ophthalmology. 1998;105(6):1004–10.PubMedCrossRef Aaberg TM, Flynn HW, Schiffman J, Newton J. Nosocomial acute-onset postoperative endophthalmitis survey: a 10-year review of incidence and outcomes. Ophthalmology. 1998;105(6):1004–10.PubMedCrossRef
11.
Zurück zum Zitat Levison AL, Mendes TS, Bhisitkul R. Post procedural endophthalmitis: a review. Expert Rev Ophthalmol. 2013;8(1):45–62.CrossRef Levison AL, Mendes TS, Bhisitkul R. Post procedural endophthalmitis: a review. Expert Rev Ophthalmol. 2013;8(1):45–62.CrossRef
12.
Zurück zum Zitat Chen X, Adelman RA. Microbial spectrum and resistance patterns in endophthalmitis: a 21-year (1988–2008) review in Northeast United States. J Ocul Pharmacol Ther. 2012;28(4):329–34.PubMedCrossRef Chen X, Adelman RA. Microbial spectrum and resistance patterns in endophthalmitis: a 21-year (1988–2008) review in Northeast United States. J Ocul Pharmacol Ther. 2012;28(4):329–34.PubMedCrossRef
13.
Zurück zum Zitat Lemley CA, Han DP. Endophthalmitis: a review of current evaluation and management. Retina. 2007;27(6):662–80.PubMedCrossRef Lemley CA, Han DP. Endophthalmitis: a review of current evaluation and management. Retina. 2007;27(6):662–80.PubMedCrossRef
14.
Zurück zum Zitat Han DP, Wisniewski SR, Wilson LA, Barza M, Vine AK, Doft BH, et al. Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol. 1996;122(1):1–17.PubMedCrossRef Han DP, Wisniewski SR, Wilson LA, Barza M, Vine AK, Doft BH, et al. Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol. 1996;122(1):1–17.PubMedCrossRef
15.
Zurück zum Zitat Johnson MW, Doft BH, Kelsey SF, Barza M, Wilson LA, Barr CC, et al. The endophthalmitis vitrectomy study: relationship between clinical presentation and microbioloaic spectrum. Ophthalmology. 1997;104(2):261–72.PubMedCrossRef Johnson MW, Doft BH, Kelsey SF, Barza M, Wilson LA, Barr CC, et al. The endophthalmitis vitrectomy study: relationship between clinical presentation and microbioloaic spectrum. Ophthalmology. 1997;104(2):261–72.PubMedCrossRef
16.
Zurück zum Zitat Charles QY, Ta CN. Prevention of postcataract endophthalmitis: evidence-based medicine. Curr Opin Ophthalmol. 2012;23(1):19–24.CrossRef Charles QY, Ta CN. Prevention of postcataract endophthalmitis: evidence-based medicine. Curr Opin Ophthalmol. 2012;23(1):19–24.CrossRef
17.
Zurück zum Zitat Al-Mezaine HS, Kangave D, Al-Assiri A, Al-Rajhi AA. Acute-onset nosocomial endophthalmitis after cataract surgery: incidence, clinical features, causative organisms, and visual outcomes. J Cataract Refract Surg. 2009;35(4):643–9.PubMedCrossRef Al-Mezaine HS, Kangave D, Al-Assiri A, Al-Rajhi AA. Acute-onset nosocomial endophthalmitis after cataract surgery: incidence, clinical features, causative organisms, and visual outcomes. J Cataract Refract Surg. 2009;35(4):643–9.PubMedCrossRef
18.
Zurück zum Zitat Lundström M, Wejde G, Stenevi U, Thorburn W, Montan P. Endophthalmitis after cataract surgery: a nationwide prospective study evaluating incidence in relation to incision type and location. Ophthalmology. 2007;114(5):866–70.PubMedCrossRef Lundström M, Wejde G, Stenevi U, Thorburn W, Montan P. Endophthalmitis after cataract surgery: a nationwide prospective study evaluating incidence in relation to incision type and location. Ophthalmology. 2007;114(5):866–70.PubMedCrossRef
19.
Zurück zum Zitat Group EES. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg. 2007;33(6):978–88.CrossRef Group EES. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg. 2007;33(6):978–88.CrossRef
20.
Zurück zum Zitat Brazitikos P, Balidis M, Tranos P, Androudi S, Papadopoulos N, Tsinopoulos I, Stangos N. Sulcus implantation of a 3-piece, 6.0 mm optic, hydrophobic foldable acrylic intraocular lens in phacoemulsification complicated by posterior capsule rupture. J Cataract Refract Surg. 2002;28(9):1618–22.PubMedCrossRef Brazitikos P, Balidis M, Tranos P, Androudi S, Papadopoulos N, Tsinopoulos I, Stangos N. Sulcus implantation of a 3-piece, 6.0 mm optic, hydrophobic foldable acrylic intraocular lens in phacoemulsification complicated by posterior capsule rupture. J Cataract Refract Surg. 2002;28(9):1618–22.PubMedCrossRef
21.
Zurück zum Zitat Galor A, Goldhardt R, Wellik SR, Gregori NZ, Flynn HW. Management strategies to reduce risk of postoperative infections. Curr Ophthalmol Rep. 2013;1(4):161–8. Galor A, Goldhardt R, Wellik SR, Gregori NZ, Flynn HW. Management strategies to reduce risk of postoperative infections. Curr Ophthalmol Rep. 2013;1(4):161–8.
22.
Zurück zum Zitat Miño DKH, Ta CN, Froehlich SJ, Schaller UC, Engelbert M, Klauss V, et al. Prospective study of risk factors for conjunctival bacterial contamination in patients undergoing intraocular surgery. Eur J Ophthalmol. 2008;19(5):717–22. Miño DKH, Ta CN, Froehlich SJ, Schaller UC, Engelbert M, Klauss V, et al. Prospective study of risk factors for conjunctival bacterial contamination in patients undergoing intraocular surgery. Eur J Ophthalmol. 2008;19(5):717–22.
23.
Zurück zum Zitat de Kaspar HM, Shriver EM, Nguyen EV, Egbert PR, Singh K, Blumenkranz MS, et al. Risk factors for antibiotic-resistant conjunctival bacterial flora in patients undergoing intraocular surgery. Graefe’s Arch Clin Exp Ophthalmol. 2003;241(9):730–3.CrossRef de Kaspar HM, Shriver EM, Nguyen EV, Egbert PR, Singh K, Blumenkranz MS, et al. Risk factors for antibiotic-resistant conjunctival bacterial flora in patients undergoing intraocular surgery. Graefe’s Arch Clin Exp Ophthalmol. 2003;241(9):730–3.CrossRef
24.
Zurück zum Zitat Tan CS, Wong HK, Yang FP. Epidemiology of postoperative endophthalmitis in an Asian population: 11-year incidence and effect of intracameral antibiotic agents. J Cataract Refract Surg. 2012;38(3):425–30.PubMedCrossRef Tan CS, Wong HK, Yang FP. Epidemiology of postoperative endophthalmitis in an Asian population: 11-year incidence and effect of intracameral antibiotic agents. J Cataract Refract Surg. 2012;38(3):425–30.PubMedCrossRef
25.
Zurück zum Zitat Keynan Y, Finkelman Y, Lagacé-Wiens P. The microbiology of endophthalmitis: global trends and a local perspective. Eur J Clin Microbiol Infect Dis. 2012;31(11):2879–86.PubMedCrossRef Keynan Y, Finkelman Y, Lagacé-Wiens P. The microbiology of endophthalmitis: global trends and a local perspective. Eur J Clin Microbiol Infect Dis. 2012;31(11):2879–86.PubMedCrossRef
26.
Zurück zum Zitat Miller JJ, Scott IU, Flynn HW, Smiddy WE, Newton J, Miller D. Acute-onset endophthalmitis after cataract surgery (2000–2004): incidence, clinical settings, and visual acuity outcomes after treatment. Am J Ophthalmol. 2005;139(6):983–7.PubMedCrossRef Miller JJ, Scott IU, Flynn HW, Smiddy WE, Newton J, Miller D. Acute-onset endophthalmitis after cataract surgery (2000–2004): incidence, clinical settings, and visual acuity outcomes after treatment. Am J Ophthalmol. 2005;139(6):983–7.PubMedCrossRef
27.
Zurück zum Zitat Parmar P, Salman A, Kaliamurthy J, Prasanth DA, Thomas PA, Jesudasan CAN. Anterior chamber contamination during phacoemulsification and manual small-incision cataract surgery. Am J Ophthalmol. 2006;141(6):1160–1.PubMedCrossRef Parmar P, Salman A, Kaliamurthy J, Prasanth DA, Thomas PA, Jesudasan CAN. Anterior chamber contamination during phacoemulsification and manual small-incision cataract surgery. Am J Ophthalmol. 2006;141(6):1160–1.PubMedCrossRef
28.
Zurück zum Zitat Romero-Aroca P, Méndez-Marin I, Salvat-Serra M, Fernández-Ballart J, Almena-Garcia M, Reyes-Torres J. Results at seven years after the use of intracamerular cefazolin as an endophthalmitis prophylaxis in cataract surgery. BMC Ophthalmol. 2012;12(1):2.PubMedPubMedCentralCrossRef Romero-Aroca P, Méndez-Marin I, Salvat-Serra M, Fernández-Ballart J, Almena-Garcia M, Reyes-Torres J. Results at seven years after the use of intracamerular cefazolin as an endophthalmitis prophylaxis in cataract surgery. BMC Ophthalmol. 2012;12(1):2.PubMedPubMedCentralCrossRef
29.
Zurück zum Zitat Barreau G, Mounier M, Marin B, Adenis J-P, Robert P-Y. Intracameral cefuroxime injection at the end of cataract surgery to reduce the incidence of endophthalmitis: French study. J Cataract Refract Surg. 2012;38(8):1370–5.PubMedCrossRef Barreau G, Mounier M, Marin B, Adenis J-P, Robert P-Y. Intracameral cefuroxime injection at the end of cataract surgery to reduce the incidence of endophthalmitis: French study. J Cataract Refract Surg. 2012;38(8):1370–5.PubMedCrossRef
30.
Zurück zum Zitat Ta CN, Chang RT, Singh K, Egbert PR, Shriver EM, Blumenkranz MS, et al. Antibiotic resistance patterns of ocular bacterial flora: a prospective study of patients undergoing anterior segment surgery. Ophthalmology. 2003;110(10):1946–51.PubMedCrossRef Ta CN, Chang RT, Singh K, Egbert PR, Shriver EM, Blumenkranz MS, et al. Antibiotic resistance patterns of ocular bacterial flora: a prospective study of patients undergoing anterior segment surgery. Ophthalmology. 2003;110(10):1946–51.PubMedCrossRef
31.
Zurück zum Zitat Group EVS. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol. 1995;113:1479–96. Group EVS. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol. 1995;113:1479–96.
32.
Zurück zum Zitat Sheng Y, Sun W, Gu Y, Lou J, Liu W. Endophthalmitis after cataract surgery in China, 1995–2009. J Cataract Refract Surg. 2011;37(9):1715–22.PubMedCrossRef Sheng Y, Sun W, Gu Y, Lou J, Liu W. Endophthalmitis after cataract surgery in China, 1995–2009. J Cataract Refract Surg. 2011;37(9):1715–22.PubMedCrossRef
33.
Zurück zum Zitat Gribomont A. General review-post-cataract surgery endophthalmitis: an update. Bull Soc Belge Ophtalmol. 2009;311:43.PubMed Gribomont A. General review-post-cataract surgery endophthalmitis: an update. Bull Soc Belge Ophtalmol. 2009;311:43.PubMed
34.
Zurück zum Zitat Wykoff CC, Flynn HW, Miller D, Scott IU, Alfonso EC. Exogenous fungal endophthalmitis: microbiology and clinical outcomes. Ophthalmology. 2008;115(9):1501–7. e2. Wykoff CC, Flynn HW, Miller D, Scott IU, Alfonso EC. Exogenous fungal endophthalmitis: microbiology and clinical outcomes. Ophthalmology. 2008;115(9):1501–7. e2.
35.
Zurück zum Zitat Kuhn F, Gini G. Ten years after … are findings of the Endophthalmitis Vitrectomy Study still relevant today? Graefe’s Arch Clin Exp Ophthalmol. 2005;243(12):1197–9. Kuhn F, Gini G. Ten years after … are findings of the Endophthalmitis Vitrectomy Study still relevant today? Graefe’s Arch Clin Exp Ophthalmol. 2005;243(12):1197–9.
36.
Zurück zum Zitat Taban M, Behrens A, Newcomb RL, Nobe MY, McDonnell PJ. Incidence of acute endophthalmitis following penetrating keratoplasty: a systematic review. Arch Ophthalmol. 2005;123(5):605–9.PubMedCrossRef Taban M, Behrens A, Newcomb RL, Nobe MY, McDonnell PJ. Incidence of acute endophthalmitis following penetrating keratoplasty: a systematic review. Arch Ophthalmol. 2005;123(5):605–9.PubMedCrossRef
37.
Zurück zum Zitat Hood CT, Lee BJ, Jeng BH. Incidence, occurrence rate, and characteristics of suture-related corneal infections after penetrating keratoplasty. Cornea. 2011;30(6):624–8.PubMedCrossRef Hood CT, Lee BJ, Jeng BH. Incidence, occurrence rate, and characteristics of suture-related corneal infections after penetrating keratoplasty. Cornea. 2011;30(6):624–8.PubMedCrossRef
38.
Zurück zum Zitat Chen JY, Jones MN, Srinivasan S, Neal TJ, Armitage WJ, Kaye SB, et al. Endophthalmitis after penetrating keratoplasty. Ophthalmology. 2015;122(1):25–30.PubMedCrossRef Chen JY, Jones MN, Srinivasan S, Neal TJ, Armitage WJ, Kaye SB, et al. Endophthalmitis after penetrating keratoplasty. Ophthalmology. 2015;122(1):25–30.PubMedCrossRef
39.
Zurück zum Zitat Kloess PM, Stulting RD, Waring GO, Wilson LA. Bacterial and fungal endophthalmitis after penetrating keratoplasty. Am J Ophthalmol. 1993;115(3):309–16.PubMedCrossRef Kloess PM, Stulting RD, Waring GO, Wilson LA. Bacterial and fungal endophthalmitis after penetrating keratoplasty. Am J Ophthalmol. 1993;115(3):309–16.PubMedCrossRef
40.
Zurück zum Zitat Kunimoto DY, Tasman W, Rapuano C, Recchia F, Busbee B, Pearlman R, et al. Endophthalmitis after penetrating keratoplasty: microbiologic spectrum and susceptibility of isolates. Am J Ophthalmol. 2004;137(2):343–5.PubMedCrossRef Kunimoto DY, Tasman W, Rapuano C, Recchia F, Busbee B, Pearlman R, et al. Endophthalmitis after penetrating keratoplasty: microbiologic spectrum and susceptibility of isolates. Am J Ophthalmol. 2004;137(2):343–5.PubMedCrossRef
41.
Zurück zum Zitat Hassan SS, Wilhelmus KR, Dahl P, Davis GC, Roberts RT, Ross KW, et al. Infectious disease risk factors of corneal graft donors. Arch Ophthalmol. 2008;126(2):235–9.PubMedPubMedCentralCrossRef Hassan SS, Wilhelmus KR, Dahl P, Davis GC, Roberts RT, Ross KW, et al. Infectious disease risk factors of corneal graft donors. Arch Ophthalmol. 2008;126(2):235–9.PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat Bor E, Kremer I. Endophthalmitis and wound dehiscence following late removal of penetrating keratoplasty sutures. Ophthalmic Surg Lasers Imaging. 2010;42(3):234–40.CrossRef Bor E, Kremer I. Endophthalmitis and wound dehiscence following late removal of penetrating keratoplasty sutures. Ophthalmic Surg Lasers Imaging. 2010;42(3):234–40.CrossRef
43.
Zurück zum Zitat Shih CY, Ritterband DC, Rubino S, Palmiero P-M, Jangi A, Liebmann J, et al. Visually significant and nonsignificant complications arising from Descemet stripping automated endothelial keratoplasty. Am J Ophthalmol. 2009;148(6):837–43.PubMedCrossRef Shih CY, Ritterband DC, Rubino S, Palmiero P-M, Jangi A, Liebmann J, et al. Visually significant and nonsignificant complications arising from Descemet stripping automated endothelial keratoplasty. Am J Ophthalmol. 2009;148(6):837–43.PubMedCrossRef
44.
Zurück zum Zitat Ramchandran RS, DiLoreto DA, Chung MM, Kleinman DM, Plotnik RP, Graman P, et al. Infectious endophthalmitis in adult eyes receiving Boston type I keratoprosthesis. Ophthalmology. 2012;119(4):674–81.PubMedCrossRef Ramchandran RS, DiLoreto DA, Chung MM, Kleinman DM, Plotnik RP, Graman P, et al. Infectious endophthalmitis in adult eyes receiving Boston type I keratoprosthesis. Ophthalmology. 2012;119(4):674–81.PubMedCrossRef
45.
Zurück zum Zitat Greiner MA, Li JY, Mannis MJ. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California. Davis. Ophthalmology. 2011;118(8):1543–50.PubMedCrossRef Greiner MA, Li JY, Mannis MJ. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California. Davis. Ophthalmology. 2011;118(8):1543–50.PubMedCrossRef
46.
Zurück zum Zitat Klufas MA, Yannuzzi NA, D’Amico DJ, Kiss S Vitreoretinal aspects of permanent keratoprosthesis. Surv Ophthalmol. 2015;60(3):216–28. Klufas MA, Yannuzzi NA, D’Amico DJ, Kiss S Vitreoretinal aspects of permanent keratoprosthesis. Surv Ophthalmol. 2015;60(3):216–28.
47.
Zurück zum Zitat Robert M-C, Moussally K, Harissi-Dagher M. Review of endophthalmitis following Boston keratoprosthesis type 1. Br J Ophthalmol. 2012;96(6):776–80.PubMedCrossRef Robert M-C, Moussally K, Harissi-Dagher M. Review of endophthalmitis following Boston keratoprosthesis type 1. Br J Ophthalmol. 2012;96(6):776–80.PubMedCrossRef
48.
Zurück zum Zitat Durand ML, Dohlman CH. Successful prevention of bacterial endophthalmitis in eyes with the Boston keratoprosthesis. Cornea. 2009;28(8):896–901.PubMedCrossRef Durand ML, Dohlman CH. Successful prevention of bacterial endophthalmitis in eyes with the Boston keratoprosthesis. Cornea. 2009;28(8):896–901.PubMedCrossRef
49.
Zurück zum Zitat Chew HF, Ayres BD, Hammersmith KM, Rapuano CJ, Laibson PR, Myers JS, et al. Boston keratoprosthesis outcomes and complications. Cornea. 2009;28(9):989–96.PubMedCrossRef Chew HF, Ayres BD, Hammersmith KM, Rapuano CJ, Laibson PR, Myers JS, et al. Boston keratoprosthesis outcomes and complications. Cornea. 2009;28(9):989–96.PubMedCrossRef
50.
Zurück zum Zitat Scott IU, Flynn HW, Feuer W, Pflugfelder SC, Alfonso EC, Forster RK, et al. Endophthalmitis associated with microbial keratitis. Ophthalmology. 1996;103(11):1864–70.PubMedCrossRef Scott IU, Flynn HW, Feuer W, Pflugfelder SC, Alfonso EC, Forster RK, et al. Endophthalmitis associated with microbial keratitis. Ophthalmology. 1996;103(11):1864–70.PubMedCrossRef
51.
Zurück zum Zitat O’Neill EC, Yeoh J, Fabinyi DC, Cassidy D, Vajpayee RB, Allen P, et al. Risk factors, microbial profiles and prognosis of microbial keratitis-associated endophthalmitis in high-risk eyes. Graefe’s Arch Clin Exp Ophthalmol. 2014;252(9):1457–62.CrossRef O’Neill EC, Yeoh J, Fabinyi DC, Cassidy D, Vajpayee RB, Allen P, et al. Risk factors, microbial profiles and prognosis of microbial keratitis-associated endophthalmitis in high-risk eyes. Graefe’s Arch Clin Exp Ophthalmol. 2014;252(9):1457–62.CrossRef
52.
Zurück zum Zitat Henry CR, Flynn HW, Miller D, Forster RK, Alfonso EC. Infectious keratitis progressing to endophthalmitis: a 15-year study of microbiology, associated factors, and clinical outcomes. Ophthalmology. 2012;119(12):2443–9.PubMedPubMedCentralCrossRef Henry CR, Flynn HW, Miller D, Forster RK, Alfonso EC. Infectious keratitis progressing to endophthalmitis: a 15-year study of microbiology, associated factors, and clinical outcomes. Ophthalmology. 2012;119(12):2443–9.PubMedPubMedCentralCrossRef
53.
Zurück zum Zitat Bharathi MJ, Ramakrishnan R, Shivakumar C, Meenakshi R, Lionalraj D. Etiology and antibacterial susceptibility pattern of community-acquired bacterial ocular infections in a tertiary eye care hospital in south India. Indian J Ophthalmol. 2010;58(6):497.PubMedPubMedCentralCrossRef Bharathi MJ, Ramakrishnan R, Shivakumar C, Meenakshi R, Lionalraj D. Etiology and antibacterial susceptibility pattern of community-acquired bacterial ocular infections in a tertiary eye care hospital in south India. Indian J Ophthalmol. 2010;58(6):497.PubMedPubMedCentralCrossRef
54.
Zurück zum Zitat Taylor S, Aylward G. Endophthalmitis following 25-gauge vitrectomy. Eye. 2005;19(11):1228–9.PubMedCrossRef Taylor S, Aylward G. Endophthalmitis following 25-gauge vitrectomy. Eye. 2005;19(11):1228–9.PubMedCrossRef
55.
Zurück zum Zitat Eifrig CW, Scott IU, Flynn HW, Smiddy WE, Newton J. Endophthalmitis after pars plana vitrectomy: incidence, causative organisms, and visual acuity outcomes. Am J Ophthalmol. 2004;138(5):799–802.PubMedCrossRef Eifrig CW, Scott IU, Flynn HW, Smiddy WE, Newton J. Endophthalmitis after pars plana vitrectomy: incidence, causative organisms, and visual acuity outcomes. Am J Ophthalmol. 2004;138(5):799–802.PubMedCrossRef
56.
Zurück zum Zitat Recchia FM, Scott IU, Brown GC, Brown MM, Ho AC, Ip MS. Small-gauge pars plana vitrectomy: a report by the American Academy of Ophthalmology. Ophthalmology. 2010;117(9):1851–7.PubMedCrossRef Recchia FM, Scott IU, Brown GC, Brown MM, Ho AC, Ip MS. Small-gauge pars plana vitrectomy: a report by the American Academy of Ophthalmology. Ophthalmology. 2010;117(9):1851–7.PubMedCrossRef
57.
Zurück zum Zitat Scott IU, Flynn HW Jr, Acar N, Dev S, Shaikh S, Mittra RA, et al. Incidence of endophthalmitis after 20-gauge vs 23-gauge vs 25-gauge pars plana vitrectomy. Graefe’s Arch Clin Exp Ophthalmol. 2011;249(3):377–80.CrossRef Scott IU, Flynn HW Jr, Acar N, Dev S, Shaikh S, Mittra RA, et al. Incidence of endophthalmitis after 20-gauge vs 23-gauge vs 25-gauge pars plana vitrectomy. Graefe’s Arch Clin Exp Ophthalmol. 2011;249(3):377–80.CrossRef
58.
Zurück zum Zitat Scott IU, Harry W, Flynn J, Dev S, Shaikh S, Mittra RA, Arevalo JF, et al. Endophthalmitis after 25-gauge and 20-gauge pars plana vitrectomy: incidence and outcomes. Retina. 2008;28(1):138–42.PubMedCrossRef Scott IU, Harry W, Flynn J, Dev S, Shaikh S, Mittra RA, Arevalo JF, et al. Endophthalmitis after 25-gauge and 20-gauge pars plana vitrectomy: incidence and outcomes. Retina. 2008;28(1):138–42.PubMedCrossRef
59.
Zurück zum Zitat Hu AY, Bourges J-L, Shah SP, Gupta A, Gonzales CR, Oliver SC, et al. Endophthalmitis after pars plana vitrectomy: a 20-and 25-gauge comparison. Ophthalmology. 2009;116(7):1360–5.PubMedCrossRef Hu AY, Bourges J-L, Shah SP, Gupta A, Gonzales CR, Oliver SC, et al. Endophthalmitis after pars plana vitrectomy: a 20-and 25-gauge comparison. Ophthalmology. 2009;116(7):1360–5.PubMedCrossRef
60.
Zurück zum Zitat Kunimoto DY, Kaiser RS, Service WER. Incidence of endophthalmitis after 20-and 25-gauge vitrectomy. Ophthalmology. 2007;114(12):2133–7.CrossRef Kunimoto DY, Kaiser RS, Service WER. Incidence of endophthalmitis after 20-and 25-gauge vitrectomy. Ophthalmology. 2007;114(12):2133–7.CrossRef
61.
Zurück zum Zitat Shah RE, Gupta O. The microsurgical safety task force: guidelines for minimizing endophthalmitis with vitrectomy surgery. Curr Opin Ophthalmol. 2012;23(3):189–94.PubMedCrossRef Shah RE, Gupta O. The microsurgical safety task force: guidelines for minimizing endophthalmitis with vitrectomy surgery. Curr Opin Ophthalmol. 2012;23(3):189–94.PubMedCrossRef
62.
Zurück zum Zitat Oshima Y, Kadonosono K, Yamaji H, Inoue M, Yoshida M, Kimura H, et al. Multicenter survey with a systematic overview of acute-onset endophthalmitis after transconjunctival microincision vitrectomy surgery. Am J Ophthalmol. 2010;150(5):716–25. e1. Oshima Y, Kadonosono K, Yamaji H, Inoue M, Yoshida M, Kimura H, et al. Multicenter survey with a systematic overview of acute-onset endophthalmitis after transconjunctival microincision vitrectomy surgery. Am J Ophthalmol. 2010;150(5):716–25. e1.
63.
Zurück zum Zitat Bahrani HM, Fazelat AA, Thomas M, Hirose T, Kroll AJ, Lou PL, Ryan EA. Endophthalmitis in the era of small gauge transconjunctival sutureless vitrectomy-meta analysis and review of literature. Semin Ophthalmol. 2010;25(5–6):275–82.PubMedCrossRef Bahrani HM, Fazelat AA, Thomas M, Hirose T, Kroll AJ, Lou PL, Ryan EA. Endophthalmitis in the era of small gauge transconjunctival sutureless vitrectomy-meta analysis and review of literature. Semin Ophthalmol. 2010;25(5–6):275–82.PubMedCrossRef
64.
Zurück zum Zitat Govetto A, Virgili G, Menchini F, Lanzetta P, Menchini U. A systematic review of endophthalmitis after microincisional versus 20-gauge vitrectomy. Ophthalmology. 2013;120(11):2286–91.PubMedCrossRef Govetto A, Virgili G, Menchini F, Lanzetta P, Menchini U. A systematic review of endophthalmitis after microincisional versus 20-gauge vitrectomy. Ophthalmology. 2013;120(11):2286–91.PubMedCrossRef
65.
Zurück zum Zitat Wu L, Berrocal MH, Arévalo JF, Carpentier C, Rodriguez FJ, Alezzandrini A, et al. Endophthalmitis after pars plana vitrectomy: results of the Pan American Collaborative Retina Study Group. Retina. 2011;31(4):673–8.PubMedCrossRef Wu L, Berrocal MH, Arévalo JF, Carpentier C, Rodriguez FJ, Alezzandrini A, et al. Endophthalmitis after pars plana vitrectomy: results of the Pan American Collaborative Retina Study Group. Retina. 2011;31(4):673–8.PubMedCrossRef
66.
Zurück zum Zitat Chiang A, Kaiser RS, Avery RL, Dugel PU, Eliott D, Shah SP, et al. Endophthalmitis in microincision vitrectomy: outcomes of gas-filled eyes. Retina. 2011;31(8):1513–7.PubMedCrossRef Chiang A, Kaiser RS, Avery RL, Dugel PU, Eliott D, Shah SP, et al. Endophthalmitis in microincision vitrectomy: outcomes of gas-filled eyes. Retina. 2011;31(8):1513–7.PubMedCrossRef
67.
Zurück zum Zitat Venkatesh P, Verma L, Tewari H. Posterior vitreous wick syndrome: a potential cause of endophthalmitis following vitreo-retinal surgery. Med Hypotheses. 2002;58(6):513–5.PubMedCrossRef Venkatesh P, Verma L, Tewari H. Posterior vitreous wick syndrome: a potential cause of endophthalmitis following vitreo-retinal surgery. Med Hypotheses. 2002;58(6):513–5.PubMedCrossRef
68.
Zurück zum Zitat Singh A, Chen JA, Stewart JM. Ocular surface fluid contamination of sutureless 25-gauge vitrectomy incisions. Retina. 2008;28(4):553–7.PubMedCrossRef Singh A, Chen JA, Stewart JM. Ocular surface fluid contamination of sutureless 25-gauge vitrectomy incisions. Retina. 2008;28(4):553–7.PubMedCrossRef
69.
Zurück zum Zitat Cochereau I. Endophthalmitis following new procedures. J Fr Ophtalmol. 2007;30(10):1067–9. Cochereau I. Endophthalmitis following new procedures. J Fr Ophtalmol. 2007;30(10):1067–9.
70.
Zurück zum Zitat Park JC, Ramasamy B, Shaw S, Prasad S, Ling RH, Foot B, et al. A prospective and nationwide study investigating endophthalmitis following pars plana vitrectomy: incidence and risk factors. Br J Ophthalmol. 2014;98(4):529–33.PubMedCrossRef Park JC, Ramasamy B, Shaw S, Prasad S, Ling RH, Foot B, et al. A prospective and nationwide study investigating endophthalmitis following pars plana vitrectomy: incidence and risk factors. Br J Ophthalmol. 2014;98(4):529–33.PubMedCrossRef
71.
Zurück zum Zitat Bacon AS, Davison CR, Patel BC, Frazer DG, Ficker LA, Dart J. Infective endophthalmitis following vitreoretinal surgery. Eye. 1993;7(pt 4):529–34.PubMedCrossRef Bacon AS, Davison CR, Patel BC, Frazer DG, Ficker LA, Dart J. Infective endophthalmitis following vitreoretinal surgery. Eye. 1993;7(pt 4):529–34.PubMedCrossRef
72.
Zurück zum Zitat Brechner RJ, Rosenfeld PJ, Babish JD, Caplan S. Pharmacotherapy for neovascular age-related macular degeneration: an analysis of the 100% 2008 medicare fee-for-service part B claims file. Am J Ophthalmol. 2011;151(5):887–95. e1. Brechner RJ, Rosenfeld PJ, Babish JD, Caplan S. Pharmacotherapy for neovascular age-related macular degeneration: an analysis of the 100% 2008 medicare fee-for-service part B claims file. Am J Ophthalmol. 2011;151(5):887–95. e1.
74.
Zurück zum Zitat Lyall D, Tey A, Foot B, Roxburgh S, Virdi M, Robertson C, et al. Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom: incidence, features, risk factors, and outcomes. Eye. 2012;26(12):1517–26.PubMedPubMedCentralCrossRef Lyall D, Tey A, Foot B, Roxburgh S, Virdi M, Robertson C, et al. Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom: incidence, features, risk factors, and outcomes. Eye. 2012;26(12):1517–26.PubMedPubMedCentralCrossRef
75.
Zurück zum Zitat Bhatt SS, Stepien KE, Joshi K. Prophylactic antibiotic use after intravitreal injection: effect on endophthalmitis rate. Retina. 2011;31(10):2032–6.PubMedPubMedCentralCrossRef Bhatt SS, Stepien KE, Joshi K. Prophylactic antibiotic use after intravitreal injection: effect on endophthalmitis rate. Retina. 2011;31(10):2032–6.PubMedPubMedCentralCrossRef
76.
Zurück zum Zitat Inoue M, Kobayakawa S, Sotozono C, Komori H, Tanaka K, Suda Y, et al. Evaluation of the incidence of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor. Ophthalmologica. 2011;226(3):145–50.PubMedCrossRef Inoue M, Kobayakawa S, Sotozono C, Komori H, Tanaka K, Suda Y, et al. Evaluation of the incidence of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor. Ophthalmologica. 2011;226(3):145–50.PubMedCrossRef
77.
Zurück zum Zitat Day S, Acquah K, Mruthyunjaya P, Grossman DS, Lee PP, Sloan FA. Ocular complications after anti-vascular endothelial growth factor therapy in medicare patients with age-related macular degeneration. Am J Ophthalmol. 2011;152(2):266–72.PubMedPubMedCentralCrossRef Day S, Acquah K, Mruthyunjaya P, Grossman DS, Lee PP, Sloan FA. Ocular complications after anti-vascular endothelial growth factor therapy in medicare patients with age-related macular degeneration. Am J Ophthalmol. 2011;152(2):266–72.PubMedPubMedCentralCrossRef
78.
Zurück zum Zitat Englander M, Chen TC, Paschalis EI, Miller JW, Kim IK. Intravitreal injections at the Massachusetts Eye and Ear Infirmary: analysis of treatment indications and postinjection endophthalmitis rates. Br J Ophthalmol. 2013;97(4):460–5.PubMedCrossRef Englander M, Chen TC, Paschalis EI, Miller JW, Kim IK. Intravitreal injections at the Massachusetts Eye and Ear Infirmary: analysis of treatment indications and postinjection endophthalmitis rates. Br J Ophthalmol. 2013;97(4):460–5.PubMedCrossRef
79.
Zurück zum Zitat Moshfeghi AA, Rosenfeld PJ, Flynn HW Jr, Schwartz SG, Davis JL, Murray TG, et al. Endophthalmitis after intravitreal anti-vascular endothelial growth factor antagonists: a six-year experience at a University Referral Center. Retina. 2011;31(4):662–8.PubMedCrossRef Moshfeghi AA, Rosenfeld PJ, Flynn HW Jr, Schwartz SG, Davis JL, Murray TG, et al. Endophthalmitis after intravitreal anti-vascular endothelial growth factor antagonists: a six-year experience at a University Referral Center. Retina. 2011;31(4):662–8.PubMedCrossRef
80.
Zurück zum Zitat Hoevenaars N, Gans D, Missotten T, van Rooij J, Lesaffre E, Van Meurs J. Suspected bacterial endophthalmitis following intravitreal anti-VEGF injection: case series and literature review. Ophthalmologica. 2012;228(3):143–7.PubMedCrossRef Hoevenaars N, Gans D, Missotten T, van Rooij J, Lesaffre E, Van Meurs J. Suspected bacterial endophthalmitis following intravitreal anti-VEGF injection: case series and literature review. Ophthalmologica. 2012;228(3):143–7.PubMedCrossRef
81.
Zurück zum Zitat Goldberg RA, Flynn HW, Isom RF, Miller D, Gonzalez S. An outbreak of streptococcus endophthalmitis after intravitreal injection of bevacizumab. Am J Ophthalmol. 2012;153(2):204–8. e1. Goldberg RA, Flynn HW, Isom RF, Miller D, Gonzalez S. An outbreak of streptococcus endophthalmitis after intravitreal injection of bevacizumab. Am J Ophthalmol. 2012;153(2):204–8. e1.
82.
Zurück zum Zitat Mccannel CA. Meta-analysis of endophthalmitis after intravitreal injection of anti–vascular endothelial growth factor agents: causative organisms and possible prevention strategies. Retina. 2011;31(4):654–61.PubMedCrossRef Mccannel CA. Meta-analysis of endophthalmitis after intravitreal injection of anti–vascular endothelial growth factor agents: causative organisms and possible prevention strategies. Retina. 2011;31(4):654–61.PubMedCrossRef
83.
Zurück zum Zitat Vaziri K, Schwartz SG, Kishor K, Flynn Jr HW. Endophthalmitis: state of the art. Clin Ophthalmol (Auckl, NZ). 2015;9:95. Vaziri K, Schwartz SG, Kishor K, Flynn Jr HW. Endophthalmitis: state of the art. Clin Ophthalmol (Auckl, NZ). 2015;9:95.
84.
Zurück zum Zitat Scott IU, Flynn HW, Feuer W. Endophthalmids after secondary intraocular lens implantation: a case–control study. Ophthalmology. 1995;102(12):1925–31.PubMedCrossRef Scott IU, Flynn HW, Feuer W. Endophthalmids after secondary intraocular lens implantation: a case–control study. Ophthalmology. 1995;102(12):1925–31.PubMedCrossRef
85.
Zurück zum Zitat Friedman DA, Mason JO III, Emond T, Mcgwin G Jr. Povidone–iodine contact time and lid speculum use during intravitreal injection. Retina. 2013;33(5):975–81.PubMedCrossRef Friedman DA, Mason JO III, Emond T, Mcgwin G Jr. Povidone–iodine contact time and lid speculum use during intravitreal injection. Retina. 2013;33(5):975–81.PubMedCrossRef
86.
Zurück zum Zitat Hsu J, Gerstenblith AT, Garg SJ, Vander JF. Conjunctival flora antibiotic resistance patterns after serial intravitreal injections without postinjection topical antibiotics. Am J Ophthalmol. 2014;157(3):514–8. e1. Hsu J, Gerstenblith AT, Garg SJ, Vander JF. Conjunctival flora antibiotic resistance patterns after serial intravitreal injections without postinjection topical antibiotics. Am J Ophthalmol. 2014;157(3):514–8. e1.
87.
Zurück zum Zitat Safar A, Dellimore MC. The effect of povidone iodine flush versus drops on conjunctival colonization before intravitreal injections. Int Ophthalmol. 2007;27(5):307–12.PubMedCrossRef Safar A, Dellimore MC. The effect of povidone iodine flush versus drops on conjunctival colonization before intravitreal injections. Int Ophthalmol. 2007;27(5):307–12.PubMedCrossRef
88.
Zurück zum Zitat Bhavsar A, Googe J Jr, Stockdale C, Bressler N, Brucker A, Elman M, et al. Diabetic Retinopathy Clinical Research Network. Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials. Arch Ophthalmol. 2009;127(12):1581–3.PubMedPubMedCentralCrossRef Bhavsar A, Googe J Jr, Stockdale C, Bressler N, Brucker A, Elman M, et al. Diabetic Retinopathy Clinical Research Network. Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials. Arch Ophthalmol. 2009;127(12):1581–3.PubMedPubMedCentralCrossRef
89.
Zurück zum Zitat Cheung CS, Wong AW, Lui A, Kertes PJ, Devenyi RG, Lam W-C. Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections. Ophthalmology. 2012;119(8):1609–14.PubMedCrossRef Cheung CS, Wong AW, Lui A, Kertes PJ, Devenyi RG, Lam W-C. Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections. Ophthalmology. 2012;119(8):1609–14.PubMedCrossRef
90.
Zurück zum Zitat Green-Simms AE, Ekdawi NS, Bakri SJ. Survey of intravitreal injection techniques among retinal specialists in the United States. Am J Ophthalmol. 2011;151(2):329–32.PubMedCrossRef Green-Simms AE, Ekdawi NS, Bakri SJ. Survey of intravitreal injection techniques among retinal specialists in the United States. Am J Ophthalmol. 2011;151(2):329–32.PubMedCrossRef
91.
Zurück zum Zitat Pilli S, Kotsolis A, Spaide RF, Slakter J, Freund KB, Sorenson J, et al. Endophthalmitis associated with intravitreal anti-vascular endothelial growth factor therapy injections in an office setting. Am J Ophthalmol. 2008;145(5):879–82.PubMedCrossRef Pilli S, Kotsolis A, Spaide RF, Slakter J, Freund KB, Sorenson J, et al. Endophthalmitis associated with intravitreal anti-vascular endothelial growth factor therapy injections in an office setting. Am J Ophthalmol. 2008;145(5):879–82.PubMedCrossRef
92.
Zurück zum Zitat Webster J, Alghamdi A. Use of plastic adhesive drapes during surgery for preventing surgical site infection. Cochrane Database Syst Rev. 2007;4:CD006353. Webster J, Alghamdi A. Use of plastic adhesive drapes during surgery for preventing surgical site infection. Cochrane Database Syst Rev. 2007;4:CD006353.
93.
Zurück zum Zitat Tailor R, Beasley R, Yang Y, Narendran N. Evaluation of patients’ experiences at different stages of the intravitreal injection procedure–what can be improved? Clin Ophthalmol (Auckl, NZ). 2011;5:1499. Tailor R, Beasley R, Yang Y, Narendran N. Evaluation of patients’ experiences at different stages of the intravitreal injection procedure–what can be improved? Clin Ophthalmol (Auckl, NZ). 2011;5:1499.
94.
Zurück zum Zitat Shimada H, Hattori T, Mori R, Nakashizuka H, Fujita K, Yuzawa M. Minimizing the endophthalmitis rate following intravitreal injections using 0.25% povidone–iodine irrigation and surgical mask. Graefe’s Arch Clin Exp Ophthalmol. 2013;251(8):1885–90. Shimada H, Hattori T, Mori R, Nakashizuka H, Fujita K, Yuzawa M. Minimizing the endophthalmitis rate following intravitreal injections using 0.25% povidone–iodine irrigation and surgical mask. Graefe’s Arch Clin Exp Ophthalmol. 2013;251(8):1885–90.
95.
Zurück zum Zitat Brynskov T, Kemp H, Sørensen TL. No cases of endophthalmitis after 20,293 intravitreal injections in an operating room setting. Retina. 2014;34(5):951–7.PubMedCrossRef Brynskov T, Kemp H, Sørensen TL. No cases of endophthalmitis after 20,293 intravitreal injections in an operating room setting. Retina. 2014;34(5):951–7.PubMedCrossRef
96.
Zurück zum Zitat Doshi RR, Leng T, Fung AE. Reducing oral flora contamination of intravitreal injections with face mask or silence. Retina. 2012;32(3):473–6.PubMed Doshi RR, Leng T, Fung AE. Reducing oral flora contamination of intravitreal injections with face mask or silence. Retina. 2012;32(3):473–6.PubMed
97.
Zurück zum Zitat Wen JC, McCannel CA, Mochon AB, Garner OB. Bacterial dispersal associated with speech in the setting of intravitreous injections. Arch Ophthalmol. 2011;129(12):1551–4.PubMedCrossRef Wen JC, McCannel CA, Mochon AB, Garner OB. Bacterial dispersal associated with speech in the setting of intravitreous injections. Arch Ophthalmol. 2011;129(12):1551–4.PubMedCrossRef
98.
Zurück zum Zitat Shah C, Garg S, Vander J, Brown G, Kaiser R, Haller J. Post-Injection Endophthalmitis (PIE) Study Team. Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. Ophthalmology. 2011;118(10):2028–34.PubMedCrossRef Shah C, Garg S, Vander J, Brown G, Kaiser R, Haller J. Post-Injection Endophthalmitis (PIE) Study Team. Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. Ophthalmology. 2011;118(10):2028–34.PubMedCrossRef
99.
Zurück zum Zitat Fineman MS, Hsu J, Spirn MJ, Kaiser RS. Bimanual assisted eyelid retraction technique for intravitreal injections. Retina. 2013;33(9):1968–70.PubMedCrossRef Fineman MS, Hsu J, Spirn MJ, Kaiser RS. Bimanual assisted eyelid retraction technique for intravitreal injections. Retina. 2013;33(9):1968–70.PubMedCrossRef
100.
Zurück zum Zitat Avery RL, Bakri SJ, Blumenkranz MS, Brucker AJ, Cunningham ET Jr, D’Amico DJ, et al. Intravitreal injection technique and monitoring: updated guidelines of an expert panel. Retina. 2014;34:S1–18.PubMedCrossRef Avery RL, Bakri SJ, Blumenkranz MS, Brucker AJ, Cunningham ET Jr, D’Amico DJ, et al. Intravitreal injection technique and monitoring: updated guidelines of an expert panel. Retina. 2014;34:S1–18.PubMedCrossRef
101.
Zurück zum Zitat Charles QY, Ta CN. Prevention and treatment of injection-related endophthalmitis. Graefe’s Arch Clin Exp Ophthalmol. 2014;252(7):1027–31. Charles QY, Ta CN. Prevention and treatment of injection-related endophthalmitis. Graefe’s Arch Clin Exp Ophthalmol. 2014;252(7):1027–31.
102.
Zurück zum Zitat Wolner B, Liebmann JM, Sassani JW, Ritch R, Speaker M, Marmor M. Late bleb-related endophthalmitis after trabeculectomy with adjunctive 5-fluorouracil. Ophthalmology. 1991;98(7):1053–60.PubMedCrossRef Wolner B, Liebmann JM, Sassani JW, Ritch R, Speaker M, Marmor M. Late bleb-related endophthalmitis after trabeculectomy with adjunctive 5-fluorouracil. Ophthalmology. 1991;98(7):1053–60.PubMedCrossRef
103.
Zurück zum Zitat DeBry PW, Perkins TW, Heatley G, Kaufman P, Brumback LC. Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin. Arch Ophthalmol. 2002;120(3):297–300.PubMedCrossRef DeBry PW, Perkins TW, Heatley G, Kaufman P, Brumback LC. Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin. Arch Ophthalmol. 2002;120(3):297–300.PubMedCrossRef
104.
Zurück zum Zitat Vaziri K, Kishor K, Schwartz SG, Maharaj AS, Moshfeghi DM, Moshfeghi AA, et al. Incidence of bleb-associated endophthalmitis in the United States. Clin Ophthalmol (Auckl, NZ). 2015;9:317. Vaziri K, Kishor K, Schwartz SG, Maharaj AS, Moshfeghi DM, Moshfeghi AA, et al. Incidence of bleb-associated endophthalmitis in the United States. Clin Ophthalmol (Auckl, NZ). 2015;9:317.
105.
Zurück zum Zitat Jampel HD, Quigley HA, Kerrigan-Baumrind LA, Melia BM, Friedman D, Barron Y. Risk factors for late-onset infection following glaucoma filtration surgery. Arch Ophthalmol. 2001;119(7):1001–8.PubMedCrossRef Jampel HD, Quigley HA, Kerrigan-Baumrind LA, Melia BM, Friedman D, Barron Y. Risk factors for late-onset infection following glaucoma filtration surgery. Arch Ophthalmol. 2001;119(7):1001–8.PubMedCrossRef
106.
Zurück zum Zitat Soltau JB, Rothman RF, Budenz DL, Greenfield DS, Feuer W, Liebmann JM, et al. Risk factors for glaucoma filtering bleb infections. Arch Ophthalmol. 2000;118(3):338–42.PubMedCrossRef Soltau JB, Rothman RF, Budenz DL, Greenfield DS, Feuer W, Liebmann JM, et al. Risk factors for glaucoma filtering bleb infections. Arch Ophthalmol. 2000;118(3):338–42.PubMedCrossRef
107.
Zurück zum Zitat Mochizuki K, Jikihara S, Ando Y, Hori N, Yamamoto T, Kitazawa Y. Incidence of delayed onset infection after trabeculectomy with adjunctive mitomycin C or 5-fluorouracil treatment. Br J Ophthalmol. 1997;81(10):877–83.PubMedPubMedCentralCrossRef Mochizuki K, Jikihara S, Ando Y, Hori N, Yamamoto T, Kitazawa Y. Incidence of delayed onset infection after trabeculectomy with adjunctive mitomycin C or 5-fluorouracil treatment. Br J Ophthalmol. 1997;81(10):877–83.PubMedPubMedCentralCrossRef
108.
Zurück zum Zitat Leng T, Miller D, Flynn HW Jr, Jacobs DJ, Gedde SJ. Delayed-onset bleb-associated endophthalmitis (1996–2008): causative organisms and visual acuity outcomes. Retina. 2011;31(2):344–52.PubMedCrossRef Leng T, Miller D, Flynn HW Jr, Jacobs DJ, Gedde SJ. Delayed-onset bleb-associated endophthalmitis (1996–2008): causative organisms and visual acuity outcomes. Retina. 2011;31(2):344–52.PubMedCrossRef
109.
Zurück zum Zitat Wallin Ö, Al-ahramy AM, Lundström M, Montan P. Endophthalmitis and severe blebitis following trabeculectomy. Epidemiology and risk factors; a single-centre retrospective study. Acta Ophthalmol. 2014;92(5):426–31.PubMedCrossRef Wallin Ö, Al-ahramy AM, Lundström M, Montan P. Endophthalmitis and severe blebitis following trabeculectomy. Epidemiology and risk factors; a single-centre retrospective study. Acta Ophthalmol. 2014;92(5):426–31.PubMedCrossRef
110.
Zurück zum Zitat Al-Turki TA, Al-Shahwan S, Al-Mezaine HS, Kangave D, Abu El-Asrar AM. Microbiology and visual outcome of bleb-associated endophthalmitis. Ocul Immunol Inflamm. 2010;18(2):121–6.PubMedCrossRef Al-Turki TA, Al-Shahwan S, Al-Mezaine HS, Kangave D, Abu El-Asrar AM. Microbiology and visual outcome of bleb-associated endophthalmitis. Ocul Immunol Inflamm. 2010;18(2):121–6.PubMedCrossRef
111.
Zurück zum Zitat Brown RH, Yang LH, Walker SD, Lynch MG, Martinez LA, Wilson LA. Treatment of bleb infection after glaucoma surgery. Arch Ophthalmol. 1994;112(1):57–61.PubMedCrossRef Brown RH, Yang LH, Walker SD, Lynch MG, Martinez LA, Wilson LA. Treatment of bleb infection after glaucoma surgery. Arch Ophthalmol. 1994;112(1):57–61.PubMedCrossRef
112.
Zurück zum Zitat Chen PP, Gedde SJ, Budenz DL, Parrish RK. Outpatient treatment of bleb infection. Arch Ophthalmol. 1997;115(9):1124–8.PubMedCrossRef Chen PP, Gedde SJ, Budenz DL, Parrish RK. Outpatient treatment of bleb infection. Arch Ophthalmol. 1997;115(9):1124–8.PubMedCrossRef
113.
Zurück zum Zitat Reynolds AC, Skuta GL, Monlux R, Johnson J. Management of blebitis by members of the American Glaucoma Society: a survey. J Glaucoma. 2001;10(4):340–7.PubMedCrossRef Reynolds AC, Skuta GL, Monlux R, Johnson J. Management of blebitis by members of the American Glaucoma Society: a survey. J Glaucoma. 2001;10(4):340–7.PubMedCrossRef
114.
Zurück zum Zitat Song A, Scott IU, Flynn MHW, Budenz DL. Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes. Ophthalmology. 2002;109(5):985–91.PubMedCrossRef Song A, Scott IU, Flynn MHW, Budenz DL. Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes. Ophthalmology. 2002;109(5):985–91.PubMedCrossRef
115.
Zurück zum Zitat Busbee BG, Recchia FM, Kaiser R, Nagra P, Rosenblatt B, Pearlman RB. Bleb-associated endophthalmitis: clinical characteristics and visual outcomes. Ophthalmology. 2004;111(8):1495–503.PubMedCrossRef Busbee BG, Recchia FM, Kaiser R, Nagra P, Rosenblatt B, Pearlman RB. Bleb-associated endophthalmitis: clinical characteristics and visual outcomes. Ophthalmology. 2004;111(8):1495–503.PubMedCrossRef
116.
Zurück zum Zitat Gedde SJ, Herndon LW, Brandt JD, Budenz DL, Feuer WJ, Schiffman JC. Postoperative complications in the tube versus trabeculectomy (TVT) study during five years of follow-up. Am J Ophthalmol. 2012;153(5):804–14.e1. Gedde SJ, Herndon LW, Brandt JD, Budenz DL, Feuer WJ, Schiffman JC. Postoperative complications in the tube versus trabeculectomy (TVT) study during five years of follow-up. Am J Ophthalmol. 2012;153(5):804–14.e1.
117.
Zurück zum Zitat Al-Torbak A, Al-Shahwan S, Al-Jadaan I, Al-Hommadi A, Edward D. Endophthalmitis associated with the Ahmed glaucoma valve implant. Br J Ophthalmol. 2005;89(4):454–8.PubMedPubMedCentralCrossRef Al-Torbak A, Al-Shahwan S, Al-Jadaan I, Al-Hommadi A, Edward D. Endophthalmitis associated with the Ahmed glaucoma valve implant. Br J Ophthalmol. 2005;89(4):454–8.PubMedPubMedCentralCrossRef
118.
Zurück zum Zitat Fan JC, Niederer RL, Von Lany H, Polkinghorne PJ. Infectious endophthalmitis: clinical features, management and visual outcomes. Clin Exp Ophthalmol. 2008;36(7):631–6. Fan JC, Niederer RL, Von Lany H, Polkinghorne PJ. Infectious endophthalmitis: clinical features, management and visual outcomes. Clin Exp Ophthalmol. 2008;36(7):631–6.
119.
Zurück zum Zitat Andreoli CM, Andreoli MT, Kloek CE, Ahuero AE, Vavvas D, Durand ML. Low rate of endophthalmitis in a large series of open globe injuries. Am J Ophthalmol. 2009;147(4):601–8. e2. Andreoli CM, Andreoli MT, Kloek CE, Ahuero AE, Vavvas D, Durand ML. Low rate of endophthalmitis in a large series of open globe injuries. Am J Ophthalmol. 2009;147(4):601–8. e2.
120.
Zurück zum Zitat Chhabra S, Kunimoto DY, Kazi L, Regillo CD, Ho AC, Belmont J, et al. Endophthalmitis after open globe injury: microbiologic spectrum and susceptibilities of isolates. Am J Ophthalmol. 2006;142(5):852–4.PubMedCrossRef Chhabra S, Kunimoto DY, Kazi L, Regillo CD, Ho AC, Belmont J, et al. Endophthalmitis after open globe injury: microbiologic spectrum and susceptibilities of isolates. Am J Ophthalmol. 2006;142(5):852–4.PubMedCrossRef
121.
Zurück zum Zitat Faghihi H, Hajizadeh F, Esfahani MR, Rasoulinejad SA, Lashay A, Mirshahi A, et al. Posttraumatic endophthalmitis: report No. 2. Retina. 2012;32(1):146–51.PubMedCrossRef Faghihi H, Hajizadeh F, Esfahani MR, Rasoulinejad SA, Lashay A, Mirshahi A, et al. Posttraumatic endophthalmitis: report No. 2. Retina. 2012;32(1):146–51.PubMedCrossRef
122.
Zurück zum Zitat Zhang Y, Zhang M, Jiang C, Yao Y, Zhang K. Endophthalmitis following open globe injury. Br J Ophthalmol. 2010;94(1):111–4.PubMedCrossRef Zhang Y, Zhang M, Jiang C, Yao Y, Zhang K. Endophthalmitis following open globe injury. Br J Ophthalmol. 2010;94(1):111–4.PubMedCrossRef
123.
Zurück zum Zitat Essex RW, Yi Q, Charles PG, Allen PJ. Post-traumatic endophthalmitis. Ophthalmology. 2004;111(11):2015–22.PubMedCrossRef Essex RW, Yi Q, Charles PG, Allen PJ. Post-traumatic endophthalmitis. Ophthalmology. 2004;111(11):2015–22.PubMedCrossRef
124.
Zurück zum Zitat Al-Omran AM, Abboud EB, El-Asrar AMA. Microbiologic spectrum and visual outcome of posttraumatic endophthalmitis. Retina. 2007;27(2):236–42. Al-Omran AM, Abboud EB, El-Asrar AMA. Microbiologic spectrum and visual outcome of posttraumatic endophthalmitis. Retina. 2007;27(2):236–42.
125.
Zurück zum Zitat Bhagat N, Nagori S, Zarbin M. Post-traumatic infectious endophthalmitis. Surv Ophthalmol. 2011;56(3):214–51.PubMedCrossRef Bhagat N, Nagori S, Zarbin M. Post-traumatic infectious endophthalmitis. Surv Ophthalmol. 2011;56(3):214–51.PubMedCrossRef
126.
Zurück zum Zitat Al-Rashaed SA, Abu El-Asrar AM. Exogenous endophthalmitis in pediatric age group. Ocul Immunol Inflamm. 2006;14(5):285–92.PubMedCrossRef Al-Rashaed SA, Abu El-Asrar AM. Exogenous endophthalmitis in pediatric age group. Ocul Immunol Inflamm. 2006;14(5):285–92.PubMedCrossRef
127.
Zurück zum Zitat Vedantham V, Nirmalan PK, Ramasamy K, Prakash K, Namperumalsamy P. Clinico-microbiological profile and visual outcomes of post-traumatic endophthalmitis at a tertiary eye care center in South India. Indian J Ophthalmol. 2006;54(1):5.PubMedCrossRef Vedantham V, Nirmalan PK, Ramasamy K, Prakash K, Namperumalsamy P. Clinico-microbiological profile and visual outcomes of post-traumatic endophthalmitis at a tertiary eye care center in South India. Indian J Ophthalmol. 2006;54(1):5.PubMedCrossRef
128.
Zurück zum Zitat Das T, Choudhury K, Sharma S, Jalali S, Nuthethi R, Endophthalmitis Research Group. Clinical profile and outcome in Bacillus endophthalmitis. Ophthalmology. 2001;108(10):1819–25.PubMedCrossRef Das T, Choudhury K, Sharma S, Jalali S, Nuthethi R, Endophthalmitis Research Group. Clinical profile and outcome in Bacillus endophthalmitis. Ophthalmology. 2001;108(10):1819–25.PubMedCrossRef
129.
Zurück zum Zitat Callegan MC, Kane ST, Cochran DC, Novosad B, Gilmore MS, Gominet M, et al. Bacillus endophthalmitis: roles of bacterial toxins and motility during infection. Invest Ophthalmol Vis Sci. 2005;46(9):3233–8.PubMedCrossRef Callegan MC, Kane ST, Cochran DC, Novosad B, Gilmore MS, Gominet M, et al. Bacillus endophthalmitis: roles of bacterial toxins and motility during infection. Invest Ophthalmol Vis Sci. 2005;46(9):3233–8.PubMedCrossRef
130.
Zurück zum Zitat Gupta A, Srinivasan R, Kaliaperumal S, Saha I. Post-traumatic fungal endophthalmitis—a prospective study. Eye. 2008;22(1):13–7.PubMedCrossRef Gupta A, Srinivasan R, Kaliaperumal S, Saha I. Post-traumatic fungal endophthalmitis—a prospective study. Eye. 2008;22(1):13–7.PubMedCrossRef
131.
Zurück zum Zitat Schmidseder E, de Kaspar HM, Kampik A, Klauß V. Post-traumatic endophthalmitis after penetrating eye injury. Risk factors, microbiological diagnosis and functional outcome. Ophthalmolge. 1998;95(3):153–7.CrossRef Schmidseder E, de Kaspar HM, Kampik A, Klauß V. Post-traumatic endophthalmitis after penetrating eye injury. Risk factors, microbiological diagnosis and functional outcome. Ophthalmolge. 1998;95(3):153–7.CrossRef
132.
Zurück zum Zitat Woodcock MG, Scott RA, Huntbach J, Kirkby GR. Mass and shape as factors in intraocular foreign body injuries. Ophthalmology. 2006;113(12):2262–9.PubMedCrossRef Woodcock MG, Scott RA, Huntbach J, Kirkby GR. Mass and shape as factors in intraocular foreign body injuries. Ophthalmology. 2006;113(12):2262–9.PubMedCrossRef
133.
Zurück zum Zitat Soheilian M, Rafati N, Mohebbi M-R, Yazdani S, Habibabadi HF, Feghhi M, et al. Prophylaxis of acute posttraumatic bacterial endophthalmitis: a multicenter, randomized clinical trial of intraocular antibiotic injection, report 2. Arch Ophthalmol. 2007;125(4):460–5.PubMedCrossRef Soheilian M, Rafati N, Mohebbi M-R, Yazdani S, Habibabadi HF, Feghhi M, et al. Prophylaxis of acute posttraumatic bacterial endophthalmitis: a multicenter, randomized clinical trial of intraocular antibiotic injection, report 2. Arch Ophthalmol. 2007;125(4):460–5.PubMedCrossRef
135.
Zurück zum Zitat Sternberg P, Martin DF. Management of endophthalmitis in the post-endophthalmitis vitrectomy study era. Arch Ophthalmol. 2001;119(5):754–5.PubMedCrossRef Sternberg P, Martin DF. Management of endophthalmitis in the post-endophthalmitis vitrectomy study era. Arch Ophthalmol. 2001;119(5):754–5.PubMedCrossRef
136.
Zurück zum Zitat Vaziri K, Pershing S, Albini TA, Moshfeghi DM, Moshfeghi AA. Risk factors predictive of endogenous endophthalmitis among hospitalized patients with hematogenous infections in the United States. Am J Ophthalmol. 2015;159(3):498–504. Vaziri K, Pershing S, Albini TA, Moshfeghi DM, Moshfeghi AA. Risk factors predictive of endogenous endophthalmitis among hospitalized patients with hematogenous infections in the United States. Am J Ophthalmol. 2015;159(3):498–504.
137.
Zurück zum Zitat Jackson TL, Paraskevopoulos T, Georgalas I. Systematic review of 342 cases of endogenous bacterial endophthalmitis. Surv Ophthalmol. 2014;59(6):627–35. Jackson TL, Paraskevopoulos T, Georgalas I. Systematic review of 342 cases of endogenous bacterial endophthalmitis. Surv Ophthalmol. 2014;59(6):627–35.
138.
Zurück zum Zitat Shankar K, Gyanendra L, Hari S, Dev Narayan S. Culture proven endogenous bacterial endophthalmitis in apparently healthy individuals. Ocul Immunol Inflamm. 2009;17(6):396–9.PubMedCrossRef Shankar K, Gyanendra L, Hari S, Dev Narayan S. Culture proven endogenous bacterial endophthalmitis in apparently healthy individuals. Ocul Immunol Inflamm. 2009;17(6):396–9.PubMedCrossRef
139.
Zurück zum Zitat Wong J-S, Chan T-K, Lee H-M, Chee S-P. Endogenous bacterial endophthalmitis: an east Asian experience and a reappraisal of a severe ocular affliction. Ophthalmology. 2000;107(8):1483–91.PubMedCrossRef Wong J-S, Chan T-K, Lee H-M, Chee S-P. Endogenous bacterial endophthalmitis: an east Asian experience and a reappraisal of a severe ocular affliction. Ophthalmology. 2000;107(8):1483–91.PubMedCrossRef
140.
Zurück zum Zitat Jackson TL, Eykyn SJ, Graham EM, Stanford MR. Endogenous bacterial endophthalmitis: a 17-year prospective series and review of 267 reported cases. Surv Ophthalmol. 2003;48(4):403–23.PubMedCrossRef Jackson TL, Eykyn SJ, Graham EM, Stanford MR. Endogenous bacterial endophthalmitis: a 17-year prospective series and review of 267 reported cases. Surv Ophthalmol. 2003;48(4):403–23.PubMedCrossRef
141.
Zurück zum Zitat Chung KS, Kim YK, Song YG, Kim CO, Han SH, Chin BS, et al. Clinical review of endogenous endophthalmitis in Korea: a 14-year review of culture positive cases of two large hospitals. Yonsei Med J. 2011;52(4):630–4.PubMedPubMedCentralCrossRef Chung KS, Kim YK, Song YG, Kim CO, Han SH, Chin BS, et al. Clinical review of endogenous endophthalmitis in Korea: a 14-year review of culture positive cases of two large hospitals. Yonsei Med J. 2011;52(4):630–4.PubMedPubMedCentralCrossRef
142.
Zurück zum Zitat Okada AA, Johnson RP, Liles WC, D’Amico DJ, Baker AS. Endogenous bacterial endophthalmitis: report of a ten-year retrospective study. Ophthalmology. 1994;101(5):832–8.PubMedCrossRef Okada AA, Johnson RP, Liles WC, D’Amico DJ, Baker AS. Endogenous bacterial endophthalmitis: report of a ten-year retrospective study. Ophthalmology. 1994;101(5):832–8.PubMedCrossRef
143.
Zurück zum Zitat Chen K-J, Hwang Y-S, Chen Y-P, Lai C-C, Chen T-L, Wang N-K. Endogenous Klebsiella endophthalmitis associated with Klebsiella pneumoniae pneumonia. Ocul Immunol Inflamm. 2009;17(3):153–9.PubMedCrossRef Chen K-J, Hwang Y-S, Chen Y-P, Lai C-C, Chen T-L, Wang N-K. Endogenous Klebsiella endophthalmitis associated with Klebsiella pneumoniae pneumonia. Ocul Immunol Inflamm. 2009;17(3):153–9.PubMedCrossRef
144.
Zurück zum Zitat Takebayashi H, Mizota A, Tanaka M. Relation between stage of endogenous fungal endophthalmitis and prognosis. Graefe’s Arch Clin Exp Ophthalmol. 2006;244(7):816–20.CrossRef Takebayashi H, Mizota A, Tanaka M. Relation between stage of endogenous fungal endophthalmitis and prognosis. Graefe’s Arch Clin Exp Ophthalmol. 2006;244(7):816–20.CrossRef
145.
Zurück zum Zitat Connell P, O’Neill E, Fabinyi D, Islam F, Buttery R, McCombe M, et al. Endogenous endophthalmitis: 10-year experience at a tertiary referral centre. Eye. 2011;25(1):66–72.PubMedPubMedCentralCrossRef Connell P, O’Neill E, Fabinyi D, Islam F, Buttery R, McCombe M, et al. Endogenous endophthalmitis: 10-year experience at a tertiary referral centre. Eye. 2011;25(1):66–72.PubMedPubMedCentralCrossRef
146.
Zurück zum Zitat Shah C, McKey J, Spirn M, Maguire J. Ocular candidiasis: a review. Br J Ophthalmol. 2008;92(4):466–8.PubMedCrossRef Shah C, McKey J, Spirn M, Maguire J. Ocular candidiasis: a review. Br J Ophthalmol. 2008;92(4):466–8.PubMedCrossRef
147.
Zurück zum Zitat Riddell Iv J, Mcneil SA, Johnson TM, Bradley SF, Kazanjian PH, Kauffman CA. Endogenous Aspergillus endophthalmitis: report of 3 cases and review of the literature. Medicine. 2002;81(4):311–20. Riddell Iv J, Mcneil SA, Johnson TM, Bradley SF, Kazanjian PH, Kauffman CA. Endogenous Aspergillus endophthalmitis: report of 3 cases and review of the literature. Medicine. 2002;81(4):311–20.
148.
Zurück zum Zitat Almeida DR, Miller D, Alfonso EC. Anterior chamber and vitreous concordance in endophthalmitis: implications for prophylaxis. Arch Ophthalmol. 2010;128(9):1136–9.PubMedCrossRef Almeida DR, Miller D, Alfonso EC. Anterior chamber and vitreous concordance in endophthalmitis: implications for prophylaxis. Arch Ophthalmol. 2010;128(9):1136–9.PubMedCrossRef
149.
Zurück zum Zitat Bispo PJM, de Melo GB, Hofling-Lima AL, Pignatari ACC. Detection and gram discrimination of bacterial pathogens from aqueous and vitreous humor using real-time PCR assays. Invest Ophthalmol Vis Sci. 2011;52(2):873–81.PubMedCrossRef Bispo PJM, de Melo GB, Hofling-Lima AL, Pignatari ACC. Detection and gram discrimination of bacterial pathogens from aqueous and vitreous humor using real-time PCR assays. Invest Ophthalmol Vis Sci. 2011;52(2):873–81.PubMedCrossRef
150.
Zurück zum Zitat Sugita S, Kamoi K, Ogawa M, Watanabe K, Shimizu N, Mochizuki M. Detection of Candida and Aspergillus species DNA using broad-range real-time PCR for fungal endophthalmitis. Graefe’s Arch Clin Exp Ophthalmol. 2012;250(3):391–8.CrossRef Sugita S, Kamoi K, Ogawa M, Watanabe K, Shimizu N, Mochizuki M. Detection of Candida and Aspergillus species DNA using broad-range real-time PCR for fungal endophthalmitis. Graefe’s Arch Clin Exp Ophthalmol. 2012;250(3):391–8.CrossRef
151.
Zurück zum Zitat Sridhar J, Flynn HW Jr, Kuriyan AE, Miller D, Albini T. Endogenous fungal endophthalmitis: risk factors, clinical features, and treatment outcomes in mold and yeast infections. J Ophthalmic Inflamm Infect. 2013;3(1):60.PubMedPubMedCentralCrossRef Sridhar J, Flynn HW Jr, Kuriyan AE, Miller D, Albini T. Endogenous fungal endophthalmitis: risk factors, clinical features, and treatment outcomes in mold and yeast infections. J Ophthalmic Inflamm Infect. 2013;3(1):60.PubMedPubMedCentralCrossRef
Metadaten
Titel
Current Perspectives of Prophylaxis and Management of Acute Infective Endophthalmitis
verfasst von
Paris Tranos
Nikolaos Dervenis
Athanasios N. Vakalis
Solon Asteriadis
Panagiotis Stavrakas
Anastasios G. P. Konstas
Publikationsdatum
02.03.2016
Verlag
Springer Healthcare
Erschienen in
Advances in Therapy / Ausgabe 5/2016
Print ISSN: 0741-238X
Elektronische ISSN: 1865-8652
DOI
https://doi.org/10.1007/s12325-016-0307-8

Weitere Artikel der Ausgabe 5/2016

Advances in Therapy 5/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.